Natural Products and Diabetes: (-)-Epicatechin and Mechanisms Involved in the Regulation of Insulin Sensitivity

Overview

Journal Handb Exp Pharmacol

Specialty Pharmacology

Date 2024 Feb 29

PMID 38421444

Authors

Cesar G Fraga

Eleonora Cremonini

Monica Galleano

Patricia I Oteiza

Affiliations

Soon will be listed here.

Abstract

Type 2 diabetes (T2D) is a disease that occurs when cells do not respond normally to insulin, a condition called insulin resistance, which leads to high blood glucose levels. Although it can be treated pharmacologically, dietary habits beyond carbohydrate restriction can be highly relevant in the management of T2D. Emerging evidence supports the possibility that natural products (NPs) could contribute to managing blood glucose or counteract the undesirable effects of hyperglycemia and insulin resistance. This chapter summarizes the relevant preclinical evidence involving the flavonoid (-)-epicatechin (EC) in the optimization of glucose homeostasis, reducing insulin resistance and/or diabetes-associated disorders. Major effects of EC are observed on (i) intestinal functions, including digestive enzymes, glucose transporters, microbiota, and intestinal permeability, and (ii) redox homeostasis, including oxidative stress and inflammation. There is still a need for further clinical studies to confirm the in vitro and rodent data, allowing recommendations for EC, particularly in prediabetic and T2D patients. The collection of similar data and the lack of clinical evidence for EC is also applicable to other NPs.

Citing Articles

Characterization of phenolic compounds and evaluation of anti-diabetic potential in L. seeds: and studies.

El-Mernissi R, El Menyiy N, Metouekel A, Zouhri A, El-Mernissi Y, Siddique F Open Life Sci. 2025; 19(1):20221024.

PMID: 39822379 PMC: 11736388. DOI: 10.1515/biol-2022-1024.

References

Actis-Goretta L, Leveques A, Giuffrida F, Romanov-Michailidis F, Viton F, Barron D . Elucidation of (-)-epicatechin metabolites after ingestion of chocolate by healthy humans. Free Radic Biol Med. 2012; 53(4):787-95. DOI: 10.1016/j.freeradbiomed.2012.05.023. View

Aguirre V, Uchida T, Yenush L, Davis R, White M . The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J Biol Chem. 2000; 275(12):9047-54. DOI: 10.1074/jbc.275.12.9047. View

Bahia P, Rattray M, Williams R . Dietary flavonoid (-)epicatechin stimulates phosphatidylinositol 3-kinase-dependent anti-oxidant response element activity and up-regulates glutathione in cortical astrocytes. J Neurochem. 2008; 106(5):2194-204. DOI: 10.1111/j.1471-4159.2008.05542.x. View

Bettaieb A, Vazquez Prieto M, Rodriguez Lanzi C, Miatello R, Haj F, Fraga C . (-)-Epicatechin mitigates high-fructose-associated insulin resistance by modulating redox signaling and endoplasmic reticulum stress. Free Radic Biol Med. 2014; 72:247-56. PMC: 4077617. DOI: 10.1016/j.freeradbiomed.2014.04.011. View

Bettaieb A, Cremonini E, Kang H, Kang J, Haj F, Oteiza P . Anti-inflammatory actions of (-)-epicatechin in the adipose tissue of obese mice. Int J Biochem Cell Biol. 2016; 81(Pt B):383-392. PMC: 5514545. DOI: 10.1016/j.biocel.2016.08.044. View

Bocci V . The neglected organ: bacterial flora has a crucial immunostimulatory role. Perspect Biol Med. 1992; 35(2):251-60. DOI: 10.1353/pbm.1992.0004. View

Cai D, Yuan M, Frantz D, Melendez P, Hansen L, Lee J . Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med. 2005; 11(2):183-90. PMC: 1440292. DOI: 10.1038/nm1166. View

Calabro V, Piotrkowski B, Fischerman L, Vazquez Prieto M, Galleano M, Fraga C . Modifications in nitric oxide and superoxide anion metabolism induced by fructose overload in rat heart are prevented by (-)-epicatechin. Food Funct. 2016; 7(4):1876-83. DOI: 10.1039/c6fo00048g. View

Campbell J, Drucker D . Pharmacology, physiology, and mechanisms of incretin hormone action. Cell Metab. 2013; 17(6):819-837. DOI: 10.1016/j.cmet.2013.04.008. View

10.

Cani P, Amar J, Iglesias M, Poggi M, Knauf C, Bastelica D . Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes. 2007; 56(7):1761-72. DOI: 10.2337/db06-1491. View

11.

Contreras T, Ricciardi E, Cremonini E, Oteiza P . (-)-Epicatechin in the prevention of tumor necrosis alpha-induced loss of Caco-2 cell barrier integrity. Arch Biochem Biophys. 2015; 573:84-91. DOI: 10.1016/j.abb.2015.01.024. View

12.

Cordero-Herrera I, Martin M, Escriva F, Alvarez C, Goya L, Ramos S . Cocoa-rich diet ameliorates hepatic insulin resistance by modulating insulin signaling and glucose homeostasis in Zucker diabetic fatty rats. J Nutr Biochem. 2015; 26(7):704-12. DOI: 10.1016/j.jnutbio.2015.01.009. View

13.

Cremonini E, Oteiza P . (-)-Epicatechin and its metabolites prevent palmitate-induced NADPH oxidase upregulation, oxidative stress and insulin resistance in HepG2 cells. Arch Biochem Biophys. 2018; 646:55-63. DOI: 10.1016/j.abb.2018.03.027. View

14.

Cremonini E, Bettaieb A, Haj F, Fraga C, Oteiza P . (-)-Epicatechin improves insulin sensitivity in high fat diet-fed mice. Arch Biochem Biophys. 2016; 599:13-21. PMC: 5523407. DOI: 10.1016/j.abb.2016.03.006. View

15.

Cremonini E, Wang Z, Bettaieb A, Adamo A, Daveri E, Mills D . (-)-Epicatechin protects the intestinal barrier from high fat diet-induced permeabilization: Implications for steatosis and insulin resistance. Redox Biol. 2017; 14:588-599. PMC: 5691220. DOI: 10.1016/j.redox.2017.11.002. View

16.

Cremonini E, Fraga C, Oteiza P . (-)-Epicatechin in the control of glucose homeostasis: Involvement of redox-regulated mechanisms. Free Radic Biol Med. 2018; 130:478-488. DOI: 10.1016/j.freeradbiomed.2018.11.010. View

17.

Cremonini E, Daveri E, Mastaloudis A, Adamo A, Mills D, Kalanetra K . Anthocyanins protect the gastrointestinal tract from high fat diet-induced alterations in redox signaling, barrier integrity and dysbiosis. Redox Biol. 2019; 26:101269. PMC: 6646927. DOI: 10.1016/j.redox.2019.101269. View

18.

Cremonini E, Iglesias D, Kang J, Lombardo G, Mostofinejad Z, Wang Z . (-)-Epicatechin and the comorbidities of obesity. Arch Biochem Biophys. 2020; 690:108505. DOI: 10.1016/j.abb.2020.108505. View

19.

Cremonini E, Daveri E, Iglesias D, Kang J, Wang Z, Gray R . A randomized placebo-controlled cross-over study on the effects of anthocyanins on inflammatory and metabolic responses to a high-fat meal in healthy subjects. Redox Biol. 2022; 51:102273. PMC: 8902616. DOI: 10.1016/j.redox.2022.102273. View

20.

Crudele L, Gadaleta R, Cariello M, Moschetta A . Gut microbiota in the pathogenesis and therapeutic approaches of diabetes. EBioMedicine. 2023; 97:104821. PMC: 10570704. DOI: 10.1016/j.ebiom.2023.104821. View